Abstract
The doxorubicin-resistant MCF-7Dox cell line derived from the drug-sensitive MCF-7 human breast carcinoma cell line, differs from the latter by a strongly reduced expression of the α2β1 integrin and a highly increased ex-pression of the α5β1 integrin. Silencing of this integrin in the MCF-7Dox cells by transfection with α5-specific siRNA markedly stimulated anoikis and increased sensitivity of these cells to doxorubicin. α5β1 silencing was also accompanied by a significant inhibition of the activity of signal protein kinases Akt and Erk2. Our results suggest involvement of common integrin-mediated signal mechanisms controlling apoptotic cell death under various stress conditions.
Similar content being viewed by others
References
Marastoni, S., Ligresti, G., Lorenzon, E., Colombatt, A., and Mongiat, M., Con. Tis. Res., 2008, vol. 49, pp. 203–206.
Hynes, R.O., Science, 2009, vol. 326, pp. 1216–1219.
Chiarugi, P. and Giannoni, E., Biochem. Pharmacol., 2008, vol. 76, pp. 1352–1364.
Elliott, T. and Sethi, T., Expert. Rev. Anticancer Ther., 2002, vol. 2, pp. 449–459.
Cheresh, D.A. and Stupack, D.G., Nature Med., 2002, vol. 8, pp. 193–194.
Berman, A.E., Kozlova, N.I., and Morozevich, G.E., Biochemistry (Moscow), 2003, vol. 68, pp. 1597–1615.
Desgrosellier, J.S. and Cheresh, D.A., Nat. Rev. Cancer, 2010, vol. 10, pp. 9–22.
Chrenek, M.A., Wong, P., and Weaver, V.M., Breast Cancer Res., 2001, vol. 3, pp. 224–229.
Damiano, J.S., Curr. Cancer Drug Targets, 2002, vol. 2, pp. 37–43.
Kozlova, N.I., Morozevich, G.E., Chubukina, A.N., and Berman, A.E., Oncogene, 2001, vol. 20, pp. 4710–4717.
Fuente, M.T., Casanova, B., Cantero, E., del Cerro, M.H., Garcia-Marco, J., Silva, A., and Garcia-Pardo, A., Biochem. Biophys. Res. Communs., 2003, vol. 311, pp. 708–712.
Rohwer, N., Welzel, M., Daskalow, K., Pfander, D., Wiedenmann, B., Detjen, K., and Cramer, T., Cancer Res., 2008, vol. 68, pp. 10113–10120.
Morozevich, G.E., Kozlova, N.I., Preobrazhenskaya, M.E., Ushakova, N.A., El’tsova, I.A., Shtil, A.A., and Berman A.E., Biochemistry (Moscow), 2006, vol. 71, pp. 607–614.
Tevyashova, A.N., Shtil, A.A., Olsufyeva, E.N., Simonova, V.S., Samusenko, A.V., and Preobrazhenskaya, M.N., J. Antibiot. (Tokyo), 2004, vol. 57, pp. 143–150.
Kozlova, N.I., Morozevich, G.E., Chubukina, A.N., Shtil, A.A., and Berman, A.E., EXCLI J., 2004, vol. 3, pp. 68–81.
Rozzo, C., Chiesa, V., Caridi, G., Pagnan, G., and Ponzoni, M., Int. J. Cancer, 1997, vol. 70, pp. 688–698.
Morozevich, G., Kozlova, N., Cheglakov, I., Ushakova, N., Berman, A., Cell Cycle, 2009, vol. 8, pp. 2219–2225.
Kuzuya, M., Satake, S., Ramos, M.A.., Kanda, S, Koike, T., Yoshino, K., Ikeda, S., and Iguchi, A., Exp Cell Res., 1999, vol. 248, pp. 498–508.
Taga, T., Suzuki, A., Gonzalez-Gomez, I., Gilles, F.H., Stins, M., Shimada, H., Barsky, L., Weinberg, K.I., and Laug, W.E., Int. J. Cancer, 2002, vol. 98, pp. 690–697.
Koistinen, P., Ahonen, M., Kahari, V.M., and Heino, J., Int. J. Cancer, 2004, vol. 112, pp. 61–70.
Matter, M.L. and Ruoslahti, E., J. Biol. Chem., 2001, vol. 276, pp. 27757–27763.
Plath, T., Detjen, K., Welzel, M., von Marschall, Z., Murphy, D., Schirner, M., Wiedenmann, B., and Rosewicz, S., J. Cell Biol., 2000, vol. 150, pp. 1467–1477.
Rohwer, N., Welzel, M., Daskalow, K., Pfander, D., Wiedenmann, B., Detjen, K., and Cramer, T., Cancer Res., 2008, vol. 68, pp. 10113–10120.
Bachelder, R.E., Marchetti, A., Falcioni, R., Soddu, S., and Mercurio, A.M., J. Biol. Chem., 1999, vol. 274, pp. 20733–20737.
Persons, D.L., Yazlovitskaya, E.M., and Pelling, J.C., J. Biol. Chem., 2000, vol. 275, pp. 35778–35785.
Schmidt, M., Hövelmann, S., and Beckers, T.L., Br. J. Cancer, 2002, vol. 87, pp. 924–932.
Vitolo, M.I., Weiss, M.B., Szmacinski, M., Tahir, K., Waldman, T., Park, B.H., Martin, S.S., Weber, D.J., and Bachman, K.E., Cancer Res., 2009, vol. 69, pp. 8275–8283.
Morozevich, G.E., Kozlova, N.I., Chubukina, A.N., El’tsov, I.A., and Berman, A.E., Biochemistry (Moscow), 2004, vol. 69, pp. 817–827.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © G.E. Morozevich, N.I. Kozlova, N.A. Ushakova, M.E. Preobrazhenskaya, A.E. Berman, 2011, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Morozevich, G.E., Kozlova, N.I., Ushakova, N.A. et al. Involvement of integrin α5β1 in apoptosis and drug resistance of human breast carcinoma cells. Biochem. Moscow Suppl. Ser. B 5, 241–245 (2011). https://doi.org/10.1134/S1990750811030085
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750811030085